CUDC-101 is a potent multi-acting HDAC (histone deacetylase), EGFR (epidermal growth factor receptor), and HER2 ( human epidermal growth factor receptor 2) inhibitor for the treatment of cancer.
分子图谱
暂无数据
点击上传数据
参考文献
• Wang, D., et al.: Med. Chem., 48, 6936 (2005)
• Bali, P., et al.: Clin. Cancer Res., 11, 6382 (2005)